Ranau District Hospital and Klinik Kesihatan Kundasang
Kota Kinabalu, Sabah, 89308, Malaysia
NCT Number: NCT06587581
The goal of this clinical trial is to learn if sending three (3) text messages per week over a six (6) months period to people with Type 2 Diabetes in areas with lack access to dietitian could help them stick to a healthier diet. The main questions it aims to answer are:
* Does a mobile phone text-message intervention improve dietary adherence among T2DM patients? * Does a mobile phone text-message intervention improve HbA1c and self-management among T2DM patients? Researchers will compare dietary adherence, HbA1c changes and self-management behaviors between the usual care group and intervention group.
Participants will:
* Be given three (3) text messages per week over a six (6) months period for the intervention group * Both usual care and intervention group will be given standard medical nutrition therapy at baseline, 3rd and 6th months visits to the clinic
Trial opening soon.
Get Notified18 year–60 year
All sexes
Interventional
Not applicable
Kota Kinabalu, Sabah, 89308, Malaysia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants from the intervention group will receive the usual care over the 6-month intervention period
Participants from the intervention group will receive the usual care and an additional three text messages per week via WhatsApp over the 6-month intervention period
Time frame: Baseline, 3-month, and 6-month
Dietary adherence to diabetic diet will be evaluated against a modified healthy eating index (HEI). A 3-day dietary record methodology (2 weekdays and 1 weekend) will be used and analyzed based on Malaysian and Singapore Food Composition Databases. The modified version of HEI used in this study consists of 14 components. Sum scores of each component yields and overall score of diet quality which will be converted into scale of zero to 100. A higher the HEI score indicates a greater adherence. The overall dietary adherence will be classified as low (below 51%), needing improvement (51-80%), or high (more than 80 points)
Time frame: Baseline, 3-month, and 6-month
Change in HbA1c will be determined by blood test at baseline, 3 and 6 months. The HbA1c result will be retrieved from the participants' routine blood result at health clinic or hospital, which will be analyzed following a standardized analytic protocol of Ministry of Health, Malaysia
Time frame: Baseline, 3-month, and 6-month
The Malay version of the Summary of Diabetes Self-Care Activities (SDSCA) will be used to measure diabetes self-management activities. The SDSCA will be used to examine the participants' compliance in performing five main self-care activities. The degree of compliance or frequency with which the person engages in each self-care behavior is considered when interpreting the SDSCA scores. Higher ratings across the board typically suggest better adherence and more active diabetes self-management.
Contact information is provided by the study sponsor or research team.
Universiti Malaysia Sabah
Other
Effectiveness of Text Messaging Intervention to Improve Dietary Behaviors Among Patients with Type 2 Diabetes Mellitus in Low Resource Area of Sabah: a Randomized, Open-Label, Controlled Trial
Acronym: DTEXT-SBH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01755494
Diabetes Mellitus, Diabetes Mellitus, Type 2
Beijing, China
View Trial DetailsNCT07635121
Diabetes Mellitus, Diabetes Mellitus Type 2
View Trial DetailsNCT07604922
Cardiovascular Diseases, Chronic Disease
Paris, France
View Trial DetailsNCT07739537
Diabete Type 2, Diabetes Mellitus
View Trial Details